Diabetic Retinopathy Clinical Trials

Mesa : Barnet Dulaney Perkins Eye Center

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Phoenix : Barnet Dulaney Perkins Eye Center

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Los Angeles : Jules Stein Eye Institute, Dept. of Ophthalmology, David Geffen School of Medicine at UCLA

Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)

Torrance : Retina Macula Institute

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Clearwater : Retina Vitreous Associates of Florida

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Fort Lauderdale : Retina Group of Florida

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

St. Petersburg : Retina Vitreous Associates of Florida

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Cedar Rapids : Iowa Eye Center

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Iowa City : University of Iowa Department of Ophthalmology and Visual Sciences

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Shawnee Mission : Retina Associates, PA

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Baltimore : Johns Hopkins Unversity

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Boston : Ophthalmic Consultants of Boston

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion

Rockland : Call EMD Serono Medical Information for information on recruiting sites

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Lynbrook : Ophthalmic Consultants of Long Island

Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study

Pittsburgh : Neuro Kinetics Inc.

Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)

Dallas : UT Southwestern Medical Center

Diabetic Retinopathy And the Myvisiontrack™ App (DRAMA) Study

Houston : Retina Consultants of Houston

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Houston : Robert Cizik Eye Clinic - University of Texas Houston

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

McAllen : Valley Retina Institute

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Tacoma : Chous Eye Care Associates

Diabetes Visual Function Supplement Study

Odense : Syddansk Universitet (SDU)

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Paris : AP - Hopitaux de Paris (AP-HP)

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Aachen : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Chemnitz : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Darmstadt : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Duesseldorf : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Essen : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Frankfurt : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Freiburg i. Br : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Hamburg : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Kiel : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Koeln : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Leipzig : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Marburg : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Muenster : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

München : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Recklinghausen : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Regensburg : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Siegburg : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Tübingen : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Ulm : Novartis Investigative Site

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Ulm : Universitaet Ulm (UUlm)

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Kochi : Amrita

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Vizag : LVPEI

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Mexico City : Conde De Valenciana

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Monterrey : Hidalgo

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

San Lucas : La Ceguera

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Coimbra : Aibili - Cec

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Barcelona : Institut Catala de la Salut - Hospital Universitari Vall d'Hebron (ICS-HUVH)

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Zurich : Department of Ophthalmology, Triemli Hospital Zurich

A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)

Ayr : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Belfast : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Birmingham : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Birmingham : Aston University (UAston)Heart of England NHS Foundation Trust

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Cardiff, : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Cheltenham : Gloucestershire Hospitals NHS Foundation Trust (CHGH)

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Colchester : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Fife : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Hull : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Liverpool : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

London : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

London : Moorfields Eye Hospital NHS Foundation Trust (MEH)

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Rugby : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

York : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment